Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
insulin preparation
long-acting insulin |
| gptkbp:alternativeTo |
gptkb:insulin
gptkb:insulin_detemir |
| gptkbp:appearance |
cloudy suspension
|
| gptkbp:brand |
gptkb:Ultralente
|
| gptkbp:contains |
zinc-insulin crystals
|
| gptkbp:duration |
20 to 36 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Insulin ultralente
|
| gptkbp:manufacturer |
gptkb:Novo_Nordisk
gptkb:Eli_Lilly |
| gptkbp:market |
discontinued
|
| gptkbp:mechanismOfAction |
regulates blood glucose
|
| gptkbp:onset |
4 to 6 hours
|
| gptkbp:peakAction |
10 to 20 hours
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:usedFor |
gptkb:diabetes_mellitus
|
| gptkbp:withdrawn |
2005
|
| gptkbp:bfsParent |
gptkb:insulin
|
| gptkbp:bfsLayer |
6
|